We are live on ! Find out more
NGM

North Growth Management Portfolio holdings

AUM $780M
1-Year Est. Return 102.77%
This Fund
S&P 500
This Quarter Est. Return
+19.06%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
–
AUM
$533M
AUM Growth
+$59.2M
Cap. Flow
-$13.4M
Cap. Flow %
-2.51%
Top 10 Hldgs %
45.94%
Holding
48
New
1
Increased
8
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$4.97M
2
GPN icon
Global Payments
GPN
+$1.42M
3
ANF icon
Abercrombie & Fitch
ANF
+$986K
4
WST icon
West Pharmaceutical
WST
+$855K
5
ATKR icon
Atkore
ATKR
+$584K

Top Sells

Rank Stock Value
1
JBL icon
Jabil
JBL
+$6M
2
CRL icon
Charles River Laboratories
CRL
+$5.87M
3
WBD icon
Warner Bros
WBD
+$4.39M
4
EAT icon
Brinker International
EAT
+$2.51M
5
ELV icon
Elevance Health
ELV
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 45.29%
2 Consumer Discretionary 24.72%
3 Industrials 15.45%
4 Healthcare 11.18%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CROX icon
26
Crocs
CROX
$6.63B
$8.65M 1.62%
85,000
– –
ELV icon
27
Elevance Health
ELV
$81.5B
$8.64M 1.62%
22,000
-6,000
-21% -$2.41M
FDX icon
28
FedEx
FDX
$73B
$7.64M 1.43%
34,000
– –
AAPL icon
29
Apple
AAPL
$4.97T
$7.61M 1.43%
37,000
– –
URI icon
30
United Rentals
URI
$65.7B
$6.46M 1.21%
9,000
– –
WBD icon
31
Warner Bros
WBD
$64.3B
$6.37M 1.19%
556,000
-471,000
-46% -$4.39M
WST icon
32
West Pharmaceutical
WST
$23.7B
$6.36M 1.19%
29,000
+4,000
+16% +$855K
TMO icon
33
Thermo Fisher Scientific
TMO
$214B
$6.18M 1.16%
15,000
+1,000
+7% +$418K
ALGN icon
34
Align Technology
ALGN
$12.9B
$6.17M 1.16%
33,000
– –
NKE icon
35
Nike
NKE
$64.1B
$6.08M 1.14%
86,000
– –
ARHS icon
36
Arhaus
ARHS
$1.07B
$6.06M 1.14%
699,000
+65,000
+10% +$543K
FBIN icon
37
Fortune Brands Innovations
FBIN
$5.86B
$5.83M 1.09%
113,000
– –
ATKR icon
38
Atkore
ATKR
$2.41B
$5.69M 1.07%
81,000
+9,000
+13% +$584K
IQV icon
39
IQVIA
IQV
$40.7B
$5.22M 0.98%
+33,000
New +$4.97M
ODFL icon
40
Old Dominion Freight Line
ODFL
$46.3B
$5M 0.94%
31,000
– –
AZO icon
41
AutoZone
AZO
$51.3B
$4.59M 0.86%
1,000
– –
BIIB icon
42
Biogen
BIIB
$30.9B
$4.27M 0.8%
34,000
– –
FSLR icon
43
First Solar
FSLR
$21.4B
$2.47M 0.46%
15,000
– –
MBC icon
44
MasterBrand
MBC
$1.09B
$2.37M 0.44%
216,000
+39,000
+22% +$432K
AMTM
45
Amentum Holdings
AMTM
$5.33B
$2.3M 0.43%
97,000
+5,000
+5% +$104K
ZYME icon
46
Zymeworks
ZYME
$1.62B
$1.22M 0.23%
97,000
– –
LULU icon
47
lululemon athletica
LULU
$13.5B
$214K 0.04%
1,000
– –
CRL icon
48
Charles River Laboratories
CRL
$11.3B
– –
-39,000
Closed -$5.87M
1
2

Similar funds

BIA
Biondo Investment Advisors Milford, Pennsylvania $780M AUM 21.03% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $781M AUM 27.1% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM

North Growth Management's Q2 2025 Portfolio in Review

As of Q2 2025, North Growth Management held 48 positions worth $533M, up 12% from $474M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 4.2%. North Growth Management opened 1 new position and exited 1, leaving the 48-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • North Growth Management's largest Q2 2025 buy was IQVIA: 33,000 shares worth $5.22M.
  • North Growth Management added most to Global Payments in Q2 2025, an estimated $1.42M increase.
  • North Growth Management's biggest Q2 2025 reduction was Jabil, cutting an estimated $6M.
  • North Growth Management fully exited Charles River Laboratories in Q2 2025, selling an estimated $5.87M.
  • North Growth Management's ten largest holdings make up 46% of its $533M portfolio in Q2 2025.
  • North Growth Management opened 1 new position and closed 1 in Q2 2025.
  • North Growth Management's portfolio value rose 12% quarter-over-quarter to $533M.

Based on North Growth Management's 13F filing for Q2 2025, filed 13 Aug 2025.